Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
R&D
Page 2
R&D
Green light to gemtuzumab ozogamicin for acute myeloid leukemia
staff
-
11 June 2018
0
Gene therapy for transfusion-dependent β-thalassemia
staff
-
11 June 2018
0
Positive top-line data from the STORM study on selinexor in patients...
staff
-
11 June 2018
0
Results of Phase 2a trial on safeproxalap for dry eye disease
staff
-
11 June 2018
0
Alnylam aligns with FDA for accelerated development of lumasiran in the...
staff
-
11 June 2018
0
New intermediate data in mycosis fungoides from a phase 1 study...
staff
-
11 June 2018
0
Industry embraces the virtual trial platforms
Cristiana Bernini
-
4 June 2018
0
A Global Commission to accelerate diagnosis in rare diseases
staff
-
13 April 2018
0
Phase 2a clinical study on Molgradex for the treatment of NTM...
staff
-
13 April 2018
0
A new kilolab plant to develop and manufacture a wider range...
staff
-
12 April 2018
0
1
2
3
...
15
Page 2 of 15
